$2.2MPre-Series A, 10 February 2026
Funds R&D, scaled manufacturing, D2C expansion and entry into Europe.
- Amount
- $2.2M
- Stage
- Pre-Series A
- Announced
- 10 February 2026
- Lead
- V3 Ventures
- Other investors
- 3i Partners, Ideaspring Capital, Litemed
- Use of funds
- Funds R&D, scaled manufacturing, D2C expansion and entry into Europe.
- Checked
- Amount and date checked against the press source
- Source
- CURAPOD raises ₹20 Cr pre-Series A for pain management device inc42.com